Czech Republic: Health system review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11230%2F15%3A10312187" target="_blank" >RIV/00216208:11230/15:10312187 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11690/15:10312187

Výsledek na webu

<a href="http://www.euro.who.int/__data/assets/pdf_file/0005/280706/Czech-HiT.pdf?ua=1" target="_blank" >http://www.euro.who.int/__data/assets/pdf_file/0005/280706/Czech-HiT.pdf?ua=1</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Czech Republic: Health system review

Popis výsledku v původním jazyce

This analysis of the Czech health system reviews recent developments in organization and governance, health financing, health-care provision, health reforms and health system performance. The Czech health-care system is based on compulsory statutory health insurance providing virtually universal coverage and a broad range of benefits, and doing so at 7.7% of GDP in 2012 - well below the EU average - of which a comparatively high 85% was publicly funded. Some important health indicators are better than the EU averages (such as mortality due to respiratory disease) or even among the best in the world (in terms of infant mortality, for example). On the other hand, mortality rates for diseases of the circulatory system and malignant neoplasms are well above the EU average, as are a range of health-care utilization rates, such as outpatient contacts and average length of stay in acute care hospitals. In short, there is substantial potential in the Czech Republic for efficiency gains and to

Název v anglickém jazyce

Czech Republic: Health system review

Popis výsledku anglicky

This analysis of the Czech health system reviews recent developments in organization and governance, health financing, health-care provision, health reforms and health system performance. The Czech health-care system is based on compulsory statutory health insurance providing virtually universal coverage and a broad range of benefits, and doing so at 7.7% of GDP in 2012 - well below the EU average - of which a comparatively high 85% was publicly funded. Some important health indicators are better than the EU averages (such as mortality due to respiratory disease) or even among the best in the world (in terms of infant mortality, for example). On the other hand, mortality rates for diseases of the circulatory system and malignant neoplasms are well above the EU average, as are a range of health-care utilization rates, such as outpatient contacts and average length of stay in acute care hospitals. In short, there is substantial potential in the Czech Republic for efficiency gains and to

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

AE - Řízení, správa a administrativa

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Health systems in transition [online]

ISSN

1817-6127

e-ISSN

—

Svazek periodika

17

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

AR - Argentinská republika

Počet stran výsledku

165

Strana od-do

1-165

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—